Send to

Choose Destination
Lancet. 1991 Jan 5;337(8732):25-7.

FK 506: an immunosuppressant for the 1990s?

Author information

Department of Medicine and Therapeutics, University of Aberdeen Medical School, UK.

Erratum in

  • Lancet 1991 Apr 13;337(8746):928.


The novel macrolide immunosuppressant FK 506 is a powerful and selective anti-T-cell agent which has a similar mode of action to that of cyclosporin. Clinical studies of FK 506 in liver allograft recipients indicate a lower risk/benefit ratio than with cyclosporin, and wider evaluation of FK 506 in transplant recipients is now under way in multicentre, prospective, controlled trials in both Europe and North America.

Comment in

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center